Drugs & TargetsFree FDA approves moxetumomab pasudotox-tdfk for hairy cell leukemia September 14, 2018Vol.44 No.34
Drugs & TargetsFree Boehringer Ingelheim acquires all ViraTherapeutics shares to develop next-gen viral-based therapies September 14, 2018Vol.44 No.34
Drugs & Targets Kymriah gets European approval for B-cell ALL and diffuse large B-cell lymphoma indications September 07, 2018Vol.44 No.33
Drugs & Targets FDA gives priority review to BMS Empliciti + pomalidomide, dexamethasone in multiple myeloma September 07, 2018Vol.44 No.33
Drugs & Targets Rafael Pharmaceuticals receives FDA Orphan Drug Designation of CPI-613 for peripheral T-cell lymphoma September 07, 2018Vol.44 No.33
Drugs & TargetsFree Imbruvica + rituximab becomes first non-chemo combination for Waldenström’s macroglobulinemia August 31, 2018Vol.44 No.32
Drugs & TargetsFree FDA approves lenvatinib for unresectable hepatocellular carcinoma August 31, 2018Vol.44 No.32
Drugs & TargetsFree Lenvima gets European approval for advanced, unresectable hepatocellular carcinoma August 31, 2018Vol.44 No.32
Drugs & TargetsFree FDA approves pembrolizumab + chemo for first-line metastatic non-squamous NSCLC August 31, 2018Vol.44 No.32
